Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,323 | 68,423 | 95,583 | 86,352 | 104,852 |
| Marketable Securities | 223,834 | 290,210 | 253,582 | 254,180 | 232,512 |
| Receivables | 95,359 | 76,552 | 64,473 | 63,101 | 52,449 |
| Inventories | 7,136 | 10,467 | 10,602 | 11,574 | 10,383 |
| Income taxes - deferred | 7,512 | 9,354 | 8,378 | 5,572 | 5,686 |
| TOTAL | $447,705 | $457,333 | $435,134 | $422,492 | $418,669 |
| Non-Current Assets | |||||
| PPE Net | 26,875 | 27,285 | 24,757 | 24,231 | 24,101 |
| Investments And Advances | 126,120 | 109,636 | 117,125 | 113,692 | 129,346 |
| Intangibles | 70,375 | 70,569 | 72,297 | 72,572 | 72,840 |
| Other Non-Current Assets | 57,953 | 52,923 | 53,748 | 57,648 | 54,297 |
| TOTAL | $281,323 | $260,413 | $267,927 | $268,143 | $280,584 |
| Total Assets | $729,028 | $717,746 | $703,061 | $690,635 | $699,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,238 | 13,575 | 11,086 | 10,141 | 7,939 |
| Accrued Expenses | 38,352 | 29,192 | 42,995 | 32,772 | 27,726 |
| TOTAL | $53,621 | $45,488 | $57,356 | $44,967 | $37,052 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,031 | 2,721 | 3,275 | 2,054 | 1,387 |
| Other Non-Current Liabilities | 10,478 | 10,138 | 10,138 | 10,008 | 10,008 |
| TOTAL | $10,478 | $10,138 | $10,138 | $10,008 | $10,008 |
| Total Liabilities | $64,099 | $55,626 | $67,494 | $54,975 | $47,060 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,655 | 80,578 | 81,403 | N/A | 84,866 |
| Common Shares | 797 | 813 | 814 | 826 | 845 |
| Retained earnings | 2,050 | -4,272 | -14,997 | -12,684 | -88 |
| Other shareholders' equity | -459 | -221 | 129 | -162 | -99 |
| TOTAL | $664,929 | $662,120 | $635,567 | $635,660 | $652,193 |
| Total Liabilities And Equity | $729,028 | $717,746 | $703,061 | $690,635 | $699,253 |